Connor, Clark & Lunn Investment Management Ltd. - COHERUS BIOSCIENCES INC ownership

COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 175 filers reported holding COHERUS BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of COHERUS BIOSCIENCES INC
ValueSharesWeighting
Q4 2022$697,134
+99.2%
88,022
+81.9%
0.00%
+100.0%
Q2 2022$350,000
-57.5%
48,389
-24.1%
0.00%
-50.0%
Q1 2022$824,000
+233.6%
63,791
+348.9%
0.00%
+300.0%
Q4 2020$247,000
-15.1%
14,211
-10.6%
0.00%
-50.0%
Q3 2020$291,000
+0.3%
15,889
-2.2%
0.00%0.0%
Q2 2020$290,00016,2410.00%
Other shareholders
COHERUS BIOSCIENCES INC shareholders Q3 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 650,000$10,374,0002.09%
CM Management, LLC 125,000$1,995,0001.51%
Perceptive Advisors 10,815,596$172,616,0001.33%
Bridge City Capital, LLC 163,198$2,605,0001.07%
Phocas Financial Corp. 514,438$8,210,0001.04%
Redwood Investments, LLC 709,184$11,319,0000.89%
Aristotle Capital Boston, LLC 2,087,187$33,312,0000.78%
Knott David M Jr 102,555$1,637,0000.56%
Zebra Capital Management LLC 16,746$267,0000.43%
Temasek Holdings (Private) Ltd 7,381,116$117,803,0000.42%
View complete list of COHERUS BIOSCIENCES INC shareholders